Small-molecule targeted cancer therapy market size in China 2017-2026
In 2021, the market size of small-molecule targeted cancer drugs in China exceeded seven billion U.S. dollars, representing a 380 percent increase from 2017. The market is expected to expand further to almost 20 billion U.S. dollars in 2026. Small-molecule drugs are drugs that can enter cells easily thanks to their low molecular weight. They can affect other molecules, such as proteins, inside the cells, and may cause cancer cells to die.